ContraFect Corporation (CFRXQ)
OTCMKTS: CFRXQ · Delayed Price · USD
0.0100
-0.0020 (-16.67%)
Jul 19, 2024, 11:17 AM EDT - Market open
ContraFect Market Cap
ContraFect has a market cap or net worth of $107.05 thousand as of July 22, 2024. Its market cap has decreased by -98.38% in one year.
Market Cap
107.05K
Enterprise Value
-2.75M
1-Year Change
-98.38%
Ranking
n/a
Category
Stock Price
$0.01
Market Cap Chart
Since September 12, 2014, ContraFect's market cap has decreased from $104.60M to $107.05K, a decrease of -99.90%. That is a compound annual growth rate of -52.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 8, 2023 | 2.50M | -34.21% |
| Dec 30, 2022 | 3.80M | -96.32% |
| Dec 31, 2021 | 103.40M | -26.35% |
| Dec 31, 2020 | 140.40M | 184.79% |
| Dec 31, 2019 | 49.30M | -59.42% |
| Dec 31, 2018 | 121.50M | 63.31% |
| Dec 29, 2017 | 74.40M | 2.20% |
| Dec 30, 2016 | 72.80M | -44.21% |
| Dec 31, 2015 | 130.50M | 84.32% |
| Dec 31, 2014 | 70.80M | -32.31% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |